These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23573972)

  • 1. JNK inhibitors as anti-inflammatory and neuroprotective agents.
    Graczyk PP
    Future Med Chem; 2013 Apr; 5(5):539-51. PubMed ID: 23573972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
    Gehringer M; Muth F; Koch P; Laufer SA
    Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents.
    Messoussi A; Feneyrolles C; Bros A; Deroide A; Daydé-Cazals B; Chevé G; Van Hijfte N; Fauvel B; Bougrin K; Yasri A
    Chem Biol; 2014 Nov; 21(11):1433-43. PubMed ID: 25442375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
    Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A
    Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
    Selness SR; Devraj RV; Monahan JB; Boehm TL; Walker JK; Devadas B; Durley RC; Kurumbail R; Shieh H; Xing L; Hepperle M; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5851-6. PubMed ID: 19751974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.
    Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A
    ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
    Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11
    Liakhov SA; Schepetkin IA; Karpenko OS; Duma HI; Haidarzhy NM; Kirpotina LN; Kovrizhina AR; Khlebnikov AI; Bagryanskaya IY; Quinn MT
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK signalling: a possible target to prevent neurodegeneration.
    Borsello T; Forloni G
    Curr Pharm Des; 2007; 13(18):1875-86. PubMed ID: 17584114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel series of 4-quinolone JNK inhibitors.
    Gong L; Tan YC; Boice G; Abbot S; McCaleb K; Iyer P; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Lukacs CM; Ursula Kammlott R; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7381-7. PubMed ID: 23142618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic promise of JNK ATP-noncompetitive inhibitors.
    Bogoyevitch MA
    Trends Mol Med; 2005 May; 11(5):232-9. PubMed ID: 15882611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of c-Jun N-terminal kinases: an update.
    Koch P; Gehringer M; Laufer SA
    J Med Chem; 2015 Jan; 58(1):72-95. PubMed ID: 25415535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration.
    Probst GD; Bowers S; Sealy JM; Truong AP; Hom RK; Galemmo RA; Konradi AW; Sham HL; Quincy DA; Pan H; Yao N; Lin M; Tóth G; Artis DR; Zmolek W; Wong K; Qin A; Lorentzen C; Nakamura DF; Quinn KP; Sauer JM; Powell K; Ruslim L; Wright S; Chereau D; Ren Z; Anderson JP; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2011 Jan; 21(1):315-9. PubMed ID: 21112785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38α mitogen-activated protein kinase inhibitors, a patent review (2005-2011).
    Fischer S; Koeberle SC; Laufer SA
    Expert Opin Ther Pat; 2011 Dec; 21(12):1843-66. PubMed ID: 22082194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting.
    Bogoyevitch MA
    Bioessays; 2006 Sep; 28(9):923-34. PubMed ID: 16937364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases.
    Kumar A; Singh UK; Kini SG; Garg V; Agrawal S; Tomar PK; Pathak P; Chaudhary A; Gupta P; Malik A
    Future Med Chem; 2015; 7(15):2065-86. PubMed ID: 26505831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological activity of novel, potent, and selective (benzoylaminomethyl)thiophene sulfonamide inhibitors of c-Jun-N-terminal kinase.
    Rückle T; Biamonte M; Grippi-Vallotton T; Arkinstall S; Cambet Y; Camps M; Chabert C; Church DJ; Halazy S; Jiang X; Martinou I; Nichols A; Sauer W; Gotteland JP
    J Med Chem; 2004 Dec; 47(27):6921-34. PubMed ID: 15615541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions.
    Ferraris D; Yang Z; Welsbie D
    Future Med Chem; 2013 Oct; 5(16):1923-34. PubMed ID: 24175744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage.
    Waetzig V; Herdegen T
    Trends Pharmacol Sci; 2005 Sep; 26(9):455-61. PubMed ID: 16054242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR studies of 1,2-diaryl-1H-benzimidazole derivatives as JNK3 inhibitors with protective effects in neuronal cells.
    Kim MH; Ryu JS; Hah JM
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1639-42. PubMed ID: 23416008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.